Healthcare Industry News: ITGI Medical
News Release - May 19, 2008
ITGI Medical Launches Over and Under(R) Pericardium Covered Stent in England, Switzerland and IrelandOR AKIVA, Israel, May 19 (HSMN NewsFeed) -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged with research, development, manufacturing and marketing of heterologous tissue covered stents, announced today the launch of the CE certified Over and Under® Pericardium Covered Stent (PCS), in the UK, Switzerland and Ireland.
"There is great unmet medical need for stents that are 100% covered, biocompatible and flexible," noted Dr. Haim Danenberg, Head of Interventional Cardiology Unit and the company's medical director. "ITGI's Over and Under® PCS is a breakthrough product that would provide the interventional cardiology the ability to separate the blood from the vessel wall while minimizing adverse events."
"Over and Under® PCS is especially suitable for patients with degenerated SVG where the lesions are less calcified than those in native coronaries," says Efri Argaman, CEO of ITGI Medical. "Over and Under®, as the rest of our heterologous covered stents, brings a new message to the interventional medicine and the therapeutic solutions the physicians can provide their patients."
At its initial step, ITGI launches Over and Under® PCS in England, one of the largest target markets in Europe. In collaboration with Pyramed, ITGI's distributor in England. In parallel, the Company launches its sales in Ireland together with its local distributor Lecks Medical and in Switzerland through Euromed Endovascular.
About Over and Under®
Over and Under® is a unique stent, first in a series of heterologous tissue covered stents, designed to set a barrier between the blood vessel wall and its lumen. Over and Under® PCS is indicated for treatment of bypass stenosis, aneurysms and for emergency situations such as perforations.
About ITGI Medical
ITGI Medical is engaged with research and development, manufacturing and marketing of heterologous tissue covered stents. Over and Under® is the first among series of heterologous covered stents designed to treat coronary lesions and aneurysms. The world stent market has a value estimation of 6.4 Billion USD, of which 37% are generated in the USA. Visit: http://www.itgimedical.com
Source: ITGI Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.